Clinical Trials Directory

Trials / Completed

CompletedNCT05815459

Mobile Observation Of Depression

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
Emteq Ltd · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers

Summary

The primary aim of this project is to test if OCOsense glasses can function as a digital phenotyping tool derived from behavioural and physiological signals related to facial expression and motion recorded using the glasses.

Detailed description

Assessment of participants living with a DSM5 research diagnosis of Bipolar disorder or Major depressive disorder as well as healthy controls who will be recruited and characterised through precision phenotyping involving cross-sectional assessment of biobehavioural and physiological markers of the symptoms of depression. Correlations between objective (i.e., OCOsense glasses captured) and subjective (i.e., self-reported) symptoms of depression will be measured within as well as across diagnoses. The resulting biobehavioral clusters will form the building block of a digital phenotyping tool based upon the wider spectrum of non-verbal behaviours and physiology defined and affected by the phenotype of depression.

Conditions

Interventions

TypeNameDescription
DEVICEOCOsenseVolunteers wear OCOsense glasses continuously during testing to monitor biobehavioural responses to tasks

Timeline

Start date
2022-07-15
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2023-04-18
Last updated
2023-05-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05815459. Inclusion in this directory is not an endorsement.